SMD Rise PCL (BKK:SMD100-R) Growth Rank: 4 (As of Jul. 08, 2026) — 33% Above Median


BKK:SMD100-R SMD Rise PCL BKK:SMD100-R
59 GF Score
Price ฿5.85
GF Value ฿24.10
! 6 Warning Signs
View Full Analysis

What is SMD Rise PCL Growth Rank?

SMD Rise PCL BKK:SMD100-R 59 Growth Rank is 4 as of Jul. 08, 2026, which is 33% above its 10-year median of 3.00. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿24.10. The stock has 6 warning signs investors should review.

SMD Rise PCL has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

BKK:SMD100-R vs MCK, CAH, COR: Growth Rank Comparison

For the Medical Distribution subindustry, SMD Rise PCL's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SMD Rise PCL Growth Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Growth Rank distribution charts can be found below:

* The bar in red indicates where SMD Rise PCL's Growth Rank falls into.


BKK:SMD100-R
59GF Score
SMD Rise PCL BKK:SMD100-R
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 4 mean?
SMD Rise PCL (BKK:SMD100-R) has a Growth Rank of 4 as of Jul. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on SMD Rise PCL and its competitors. This is 33% above median its historical median of 3.00. Over the past decade, SMD Rise PCL's Growth Rank has ranged from 1.00 to 4.00.
Is SMD Rise PCL's Growth Rank too high?
SMD Rise PCL's current Growth Rank of 4 is 33% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 4.00. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Growth Rank compare to MCK and CAH?
SMD Rise PCL's Growth Rank of 4 can be compared against companies in the Medical Distribution industry. Historically, SMD Rise PCL's own Growth Rank has ranged from 1.00 to 4.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Distribution company?
A good Growth Rank depends on the Medical Distribution industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on SMD Rise PCL and its competitors. SMD Rise PCL's current Growth Rank is 4, which is 33% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Growth Rank of 4. The stock's GF Value™ is ฿24.10, compared to a current price of ฿5.85 — trading 75.7% below its estimated fair value. The current Growth Rank is 4, which is 33% above median its 10-year median of 3.00. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Growth Rank is 4 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?

Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued. The current stock price of ฿5.85 is trading 75.7% below its estimated GF Value™ of ฿24.10.

Key valuation signals for BKK:SMD100-R:

  • Growth Rank: 4 (33% above median its 10-year median of 3.00)
  • GF Value™: ฿24.10 vs. price of ฿5.85 (75.7% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SMD Rise PCL Business Description

Other Exchanges SMD100:Thailand
Address 222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score

Get the complete analysis for BKK:SMD100-R

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.85
Price
฿24.10
GF Value